Lantern Pharma SG&A Expense (Semi Annual) Analysis

Lantern Pharma, Inc. (LTRN)

1.62 +0.20 (+14.08%) USD | NASDAQ | Apr 02, 16:00

1.56 -0.06 (-3.70%) After-Hours: 20:00

View SG&A Expense (Semi Annual) for LTRN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Semi Annual) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (Semi Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (Semi Annual) Benchmarks

Start Trial

Vertex Pharmaceuticals, Inc.	--
BioVie, Inc.	--
Acurx Pharmaceuticals, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--